Robert O'Donnell is an Oncology physician. ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2279 45th Street
Sacramento, CA 958172229
Telephone
916-734-5959Registry record last updated 22 Aug 2019.
Clinical trials
3 registered studies on ClinicalTrials.gov matched to this name. Itemized trial rows, roles and sponsors are part of the full profile. Why? →
Medicare prescribing footprint (2020)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
40.5%Other antiepileptics24.3%Levetiracetam75%Vimpat25%Part D<11 patientsAtypical Antipsychotic6.5%Olanzapine100%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
20.6%Serotonin-3 Receptor Antagonist13.8%Ondansetron Hcl100%Part D≥11 patientsProton pump inhibitor6.9%Omeprazole100%Part D<11 patientsSensory organs
12.6%Corticosteroid12.6%Dexamethasone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 1999–2015 per NIH RePORTER. The latest:
- Immunoliposomal Therapy of non-Hodgkin's Lymphoma
Va Northern California Health Care Sys
FY2015I01BX000654 - Immunoliposomal Therapy of non-Hodgkin's Lymphoma
Va Northern California Health Care Sys
FY2014I01BX000654 - Immunoliposomal Therapy of non-Hodgkin's Lymphoma
Va Northern California Health Care Sys
FY2013I01BX000654
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”